title: Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera.
abstract: Polycythemia vera (PV) is a clonal stem cell disorder characterized by hyperproliferation of the erythroid, myeloid, and megakaryocytic lineages. Although it has been shown that progenitor cells of patients with PV are hypersensitive to several growth factors, the molecular pathogenesis of this disease remains unknown. To investigate the molecular defects underlying PV, we used subtractive hybridization to isolate complementary DNAs (cDNAs) differentially expressed in patients with PV versus normal controls. We isolated a novel gene, subsequently named PRV-1, which is highly expressed in granulocytes from patients with PV (n = 19), but not detectable in normal control granulocytes (n = 21). Moreover, PRV-1 is not expressed in mononuclear cells from patients with chronic myelogenous leukemia (n = 4) or acute myelogenous leukemia (n = 5) or in granulocytes from patients with essential thrombocythemia (n = 4) or secondary erythrocytosis (n = 4). Northern blot analysis showed that PRV-1 is highly expressed in normal human bone marrow and to a much lesser degree in fetal liver. It is not expressed in a variety of other tissues tested. Although PRV-1 is not expressed in resting granulocytes from normal controls, stimulation of these cells with granulocyte colony-stimulating factor induces PRV-1 expression. The PRV-1 cDNA encodes an open reading frame of 437 amino acids, which contains a signal peptide at the N-terminus and a hydrophobic segment at the C-terminus. In addition, PRV-1 contains 2 cysteine-rich domains homologous to those found in the uPAR/Ly6/CD59/snake toxin-receptor superfamily. We therefore propose that PRV-1 represents a novel hematopoietic receptor. (Blood. 2000;95:2569-2576)
authors.affiliation: Department of Experimental Anaesthesiology, University Hospital Freiburg, Center for Tumor Biology, Freiburg, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Temerinac
authors.forename: S
authors.initials: S
authors.lastname: Klippel
authors.forename: E
authors.initials: E
authors.lastname: Strunck
authors.forename: S
authors.initials: S
authors.lastname: Röder
authors.forename: M
authors.initials: M
authors.lastname: Lübbert
authors.forename: W
authors.initials: W
authors.lastname: Lange
authors.forename: M
authors.initials: M
authors.lastname: Azemar
authors.forename: G
authors.initials: G
authors.lastname: Meinhardt
authors.forename: H E
authors.initials: HE
authors.lastname: Schaefer
authors.forename: H L
authors.initials: HL
authors.lastname: Pahl
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000595:Amino Acid Sequence; D003001:Cloning, Molecular; D018076:DNA, Complementary / Q000032:analysis / Q000235:genetics*; D005260:Female; D015870:Gene Expression; D006098:Granulocytes / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009928:Organ Specificity; D011087:Polycythemia Vera / Q000097:blood / Q000235:genetics*; D011956:Receptors, Cell Surface / Q000235:genetics*; D055293:Receptors, Urokinase Plasminogen Activator
chemical_list: D018076:DNA, Complementary; C524898:PLAUR protein, human; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator